Breaking News, Collaborations & Alliances

Phlow, Enveda Share Progress on AI-Powered API Manufacturing Collaboration

Nearly 20,000 unique reactions were generated and analyzed in just three months, creating one of the largest high-quality datasets of its kind.

Author Image

By: Patrick Lavery

Content Marketing Editor

A joint pilot program between the American CDMO Phlow and biotechnology company Enveda is advancing AI-driven active pharmaceutical ingredient (API) manufacturing process development. The companies reported their efforts demonstrate that high-quality, internally generated reaction data can significantly improve certain AI-based predictions. Those data include clinical reaction kinetics, yields, and purity profiles. How AI Impacts APIs Ideally, Phlow and Enveda said, the data can compres...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters